Clinical Data Management
This online interactive IT-system represents a complete Longevity Industry in Greater Manchester. Given that the Longevity Industry continues to grow in size but remains highly fragmented, this platform aims to deliver a tangible and pragmatic industry unification framework. It consists of a vast industry database and includes different Longevity Industry entities, such as various companies, investors, R&D centres, hubs & accelerators. These entities are further subdivided into distinct industry subsectors such as Geroscience, FemTech, Wellness & Fitness, Regenerative Medicine, Social Care, FinTech, Age-friendly Banks, InsurTech, BioTech, Clinical Data Management, NeuroTech, AI for Longevity, PharmTech, AgeTech, Diagnostics, P4 Medicine. Furthermore, the platform emphasizes interactions, relations, and connections between the aforementioned industry entities, providing a more dynamic lens to view emerging trends and activities in this sphere. This platform enables complex interactions between industry entities and stakeholders to be visualized, filtered, searched, and thus more easily understood. It is continuously updated with real-time industry developments. It is in a constant state of expansion and refinement, with substantial additions planned on the next stage, including automation of data aggregation and advanced statistical tools including machine learning and big data analysis to enable hidden insights, connections, trends, and tangible, pragmatic answers to key strategic questions to be delivered under the weight of even larger amounts of data. This IT-platform serves as a framework for industry optimization and cross-disciplinary dialogue and collaboration between companies, investors, entrepreneurs, scientists, and, especially, government officials. In this manner, the platform maintains its relevance in the face of changing industry trends, developments, and complexities. It enables both industry participants and platform users to understand key insights relevant to developments in the sector to optimize their strategic decision-making and promote the synergistic and integrated development of the Longevity Industry to maximize the benefits of all industry stakeholders.